Gloria Barone
Overview
Explore the profile of Gloria Barone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, et al.
Front Oncol
. 2023 Jun;
13:1163768.
PMID: 37324003
Background: The Spinnaker study evaluated survival outcomes and prognostic factors in patients with advanced non-small-cell lung cancer receiving first-line chemoimmunotherapy in the real world. This sub-analysis assessed the immunotherapy-related adverse...
2.
Anpalakhan S, Huddar P, Behrouzi R, Signori A, Cave J, Comins C, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675262
GCSF prophylaxis is recommended in patients on chemotherapy with a >20% risk of febrile neutropenia and is to be considered if there is an intermediate risk of 10−20%. GCSF has...
3.
Banna G, Cantale O, Muthuramalingam S, Cave J, Comins C, Cortellini A, et al.
Int Immunopharmacol
. 2022 Jul;
110:108985.
PMID: 35777264
Background: Efficacy outcomes and prognostic factors of real-world patients with advanced non-small cell lung cancer (aNSCLC) treated with first-line chemoimmunotherapy are still limited. Patients And Methods: In the retrospective Spinnaker...
4.
Middleton G, Brock K, Savage J, Mant R, Summers Y, Connibear J, et al.
Lancet Respir Med
. 2020 Mar;
8(9):895-904.
PMID: 32199466
Background: Therapeutic blockade of the axis of programmed cell death 1 (PD-1) and its ligand (PD-L1) has transformed the management of non-small-cell lung cancer (NSCLC). Clinical trials with pembrolizumab have...
5.
Pietrantonio F, Perrone F, Biondani P, Maggi C, Lampis A, Bertan C, et al.
Cancer Biol Ther
. 2013 Sep;
14(12):1098-103.
PMID: 24025413
Background: Few data are available outlining outcomes of panitumumab in advanced colorectal cancer patients benefiting from prior cetuximab-based regimens. Patients And Methods: Thirty patients with KRAS wild type metastatic colorectal...
6.
Malaguarnera M, Greco F, Barone G, Gargante M, Malaguarnera M, Toscano M
Dig Dis Sci
. 2007 Mar;
52(11):3259-65.
PMID: 17393330
Minimal hepatic encephalopathy (MHE) describes patients with chronic liver disease or cirrhosis who have no clinical symptoms of brain dysfunction but perform worse on psychometric tests compared with healthy subjects....
7.
Malaguarnera M, Risino C, Gargante M, Oreste G, Barone G, Tomasello A, et al.
World J Gastroenterol
. 2006 Jul;
12(28):4541-5.
PMID: 16874868
Aim: To evaluate the levels of serum carnitine in patients with cancer in digestive organs and to compare them with other cancers in order to provide new insights into the...